MicroRNA-296-5p inhibits cell proliferation by targeting HMGA1 in colorectal cancer.

Experimental and Therapeutic Medicine
Guohui YanYang Zhang

Abstract

An increasing body of evidence indicates the involvement of microRNAs (miRNAs/miRs) in the initiation and progression of colorectal cancer (CRC). miR-296-5p was recently identified as a tumor suppressor in a variety of human cancer types; however, its function in CRC remains largely unknown. The present study demonstrated that the expression of miR-296-5p was significantly downregulated in CRC tissues and cell lines. The overexpression of miR-296-5p markedly inhibited proliferation, and induced cell cycle arrest and apoptosis in CRC cells. Bioinformatics analysis suggested that high mobility group AT-hook 1 (HMGA1) may be a target of miR-296-5p in CRC cells. Further experiments showed that miR-296-5p bound the 3'-untranslated region of HMGA1 and decreased its expression in CRC cells. HMGA1 was overexpressed in CRC tissues and was inversely correlated with the expression of miR-296-5p. The restoration of HMGA1 significantly reversed the inhibitory effect of miR-296-5p on the proliferation of CRC cells. Overall, the findings of the present study indicate that miR-296-5p suppressed the progression of CRC, at least partially via targeting HMGA1. Thus, miR-296-5p is a potential target for novel therapies in CRC.

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Sep 17, 2004·Nature·Victor Ambros
Jun 11, 2010·Annual Review of Biochemistry·Marc Robert FabianWitold Filipowicz
Aug 24, 2010·Cancer Science·Pieter Bas KwakYukihide Tomari
Dec 3, 2010·The Journal of Pathology·Thalia A FaraziThomas Tuschl
Feb 22, 2012·EMBO Molecular Medicine·Marilena V Iorio, Carlo M Croce
Nov 30, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Zhiting DengHairong Zheng
Nov 8, 2014·Nucleic Acids Research·Nathan Wong, Xiaowei Wang
Jan 31, 2015·Seminars in Liver Disease·Ashley M Mohr, Justin L Mott
Apr 29, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marwan G Fakih
Aug 13, 2015·Journal of Translational Medicine·Danielle MaiaAndre Luiz Vettore
Jan 26, 2016·Biochemical and Biophysical Research Communications·Wen-bin ZhouLi-ping Liu
May 14, 2016·Oncology Reports·Xiaowen ZhangMing Chen
Jul 28, 2016·Reviews of Physiology, Biochemistry and Pharmacology·Amir Abbas MomtaziAmirhossein Sahebkar
Aug 4, 2016·Clinical Interventions in Aging·Karen Simon
Aug 4, 2016·Expert Opinion on Therapeutic Targets·Marianna ColamaioAlfredo Fusco
Aug 27, 2016·Experimental & Molecular Medicine·Dae Kyoung KimJae Ho Kim
Dec 8, 2016·Best Practice & Research. Clinical Endocrinology & Metabolism·Erica GentilinMaria Chiara Zatelli
May 4, 2017·Molecular Carcinogenesis·Cristina QuintavalleMatthias S Matter
Aug 5, 2017·Cell Death and Differentiation·Andrea ConteGiovanna Maria Pierantoni
Feb 3, 2018·International Journal of Molecular Medicine·Maria Teresa ValentiMonica Mottes
Mar 10, 2018·Journal of Cellular Physiology·Nayer HosseinahliBehzad Baradaran
Apr 11, 2018·Journal of the National Comprehensive Cancer Network : JNCCN·Al B BensonDeborah A Freedman-Cass
Oct 12, 2018·Nanomedicine : Nanotechnology, Biology, and Medicine·Alessandro CapoPierlorenzo Pallante
Nov 30, 2018·Journal of Experimental & Clinical Cancer Research : CR·Dong-Min ShiWei-Zhong Wu
Dec 12, 2018·Journal of Cellular Physiology·Zahra AsadzadehBehzad Baradaran
Mar 26, 2019·Current Protein & Peptide Science·Sameer ChaudharyPrasanna R Kolatkar
Dec 5, 2019·World Journal of Clinical Cases·Hussein SabitHuseyin Tombuloglu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis